Immunohistochemical prediction of lapatinib efficacy in advanced HER2-positive breast cancer patients

Molecular mechanisms of lapatinib resistance in breast cancer are not well understood. The aim of this study was to correlate expression of selected proteins involved in ErbB family signaling pathways with clinical efficacy of lapatinib. Study group included 270 HER2-positive advanced breast cancer...

Descripción completa

Detalles Bibliográficos
Autores principales: Duchnowska, Renata, Wysocki, Piotr J., Korski, Konstanty, Czartoryska-Arłukowicz, Bogumiła, Niwińska, Anna, Orlikowska, Marlena, Radecka, Barbara, Studziński, Maciej, Demlova, Regina, Ziółkowska, Barbara, Merdalska, Monika, Hajac, Łukasz, Myśliwiec, Paulina, Zuziak, Dorota, Dębska-Szmich, Sylwia, Lang, Istvan, Foszczyńska-Kłoda, Małgorzata, Karczmarek-Borowska, Bożenna, Żawrocki, Anton, Kowalczyk, Anna, Biernat, Wojciech, Jassem, Jacek
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2015
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4808017/
https://www.ncbi.nlm.nih.gov/pubmed/26623720

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4808017/
https://www.ncbi.nlm.nih.gov/pubmed/26623720

Ejemplares similares